Saturday 17 October 2026
Export EHC’s income statement to Excel — free account
Encompass Health Corporation
EHC Healthcare Medical Care Facilities
Encompass Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.9 billion, up 10.5% from fiscal 2024. In the quarter to June 2026, revenue grew 9.58%, EPS grew 9.93%, free cash flow fell 45.0% and total debt rose 7.09%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for five, operating cash flow growth for three.
127.87
0.10
+0.08%
Follow EHC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
11.95 | 14.92 | 16.53 | 15.10 | 22.92 | 12.51 | 21.94 | 19.13 | 20.30 | 18.85 |
Piotroski F-Score |
7 | 6 | 6 | 5 | 5 | 6 | 6 | 6 | 6 | 7 |
Altman Z-Score |
1.32 | 1.58 | 1.78 | 1.75 | 1.68 | 1.64 | 2.13 | 2.35 | 2.92 | 3.25 |
P/S ratio |
0.81 | 0.98 | 1.12 | 1.17 | 1.82 | 1.28 | 1.36 | 1.39 | 1.72 | 1.80 |
P/FCF ratio |
6.39 | 9.27 | 9.77 | 24.35 | 23.53 | 36.35 | 64.04 | 28.07 | 27.90 | 26.04 |
Altman Z″-Score (non-manufacturers) |
0.43 | 0.77 | 0.70 | 0.92 | 1.12 | 1.43 | 1.49 | 1.84 | 2.12 | 2.53 |
P/Operating CF |
20.94 | 25.30 | 26.94 | 25.05 | 23.19 | 41.52 | 34.25 | 33.25 | 33.09 | 30.83 |
Beneish M-Score |
(2.73) | (2.68) | (2.81) | (2.55) | (2.57) | (2.75) | (2.86) | (2.66) | (2.76) | (2.71) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 77 |
P/B ratio |
3.17 | 2.75 | 3.09 | 3.19 | 3.29 | 2.18 | 3.23 | 2.96 | 3.30 | 3.32 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.35 | 21.01 | 9.61 | 7.62 | 6.70 |
EV/Sales |
1.61 | 1.61 | 1.68 | 1.80 | 2.66 | 2.07 | 1.98 | 1.94 | 2.16 | 2.20 |
EV/EBITDA |
7.02 | 7.57 | 8.63 | 9.15 | 12.90 | 9.38 | 9.75 | 9.15 | 9.89 | 9.39 |
EV/Operating CF |
9.16 | 9.56 | 9.43 | 13.08 | 13.46 | 11.60 | 12.20 | 10.92 | 11.57 | 11.10 |
EV/FCF |
12.71 | 15.22 | 14.62 | 37.47 | 34.40 | 58.74 | 93.51 | 39.02 | 35.08 | 31.87 |
Quick Ratio |
1.15 | 1.14 | 0.89 | 0.91 | 1.20 | 0.84 | 1.02 | 1.09 | 0.86 | 0.86 |
Current Ratio |
1.38 | 1.36 | 0.98 | 1.05 | 1.32 | 1.23 | 1.25 | 1.28 | 1.05 | 1.08 |
Net Debt/EBITDA |
3.49 | 2.96 | 2.86 | 3.21 | 4.08 | 3.57 | 3.07 | 2.57 | 2.02 | 1.72 |
Debt/Assets |
64.43% | 52.99% | 48.59% | 50.37% | 51.02% | 47.75% | 49.09% | 44.45% | 38.22% | 35.13% |
Debt/Equity |
3.25 | 1.85 | 1.61 | 1.81 | 1.67 | 1.39 | 1.52 | 1.20 | 0.89 | 0.77 |
Asset Turnover |
0.78 | 0.82 | 0.85 | 0.82 | 0.57 | 0.60 | 0.70 | 0.82 | 0.85 | 0.87 |
Operating CF/Net income |
2.59 | 2.43 | 2.61 | 1.77 | 2.48 | 1.74 | 2.60 | 2.42 | 2.20 | 2.08 |
Capex/Depreciation |
(0.96) | (1.29) | (1.36) | (1.81) | (1.92) | (2.43) | (2.35) | (2.06) | (2.08) | (2.18) |
Interest Coverage |
3.77 | 4.14 | 4.27 | 4.29 | 2.86 | 4.01 | 3.59 | 5.10 | 6.29 | 8.55 |
| 28.99% | 23.33% | 19.80% | 22.07% | 15.52% | 19.05% | 12.96% | 17.25% | 18.06% | 18.84% | |
| 5.33% | 5.68% | 5.82% | 6.37% | 4.54% | 6.19% | 4.34% | 6.00% | 7.21% | 8.31% | |
ROIC |
10.55% | 10.35% | 9.98% | 9.30% | 6.61% | 7.45% | 8.68% | 9.40% | 10.45% | 11.74% |
Return on Tangible Assets |
15.76% | 15.93% | 17.99% | 17.99% | 11.66% | 14.97% | 8.80% | 10.10% | 12.35% | 13.57% |
Average Days of Receivables |
44.47 | 44.03 | 39.91 | 40.11 | 58.62 | 46.89 | 45.06 | 46.50 | 40.68 | 38.08 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
62.02% | 63.25% | 63.89% | 64.88% | 62.43% | 61.79% | 63.23% | 62.90% | 62.33% | 60.76% |
Intangible Assets out of Total Assets |
0.50 | 0.49 | 0.49 | 0.46 | 0.43 | 0.20 | 0.27 | 0.26 | 0.24 | 0.23 |
Share Based Compensation of Revenue |
0.75% | 1.22% | 2.01% | 2.48% | 0.72% | 0.72% | 0.67% | 1.05% | 0.90% | 0.95% |
Graham Net Nets |
(1.05) | (0.72) | (0.62) | (0.67) | (0.54) | (0.70) | (0.52) | (0.45) | (0.31) | (0.28) |
Graham Number |
25.49 | 30.30 | 32.60 | 37.67 | 35.92 | 47.15 | 33.50 | 42.31 | 53.50 | 63.68 |
Earnings Yield |
8.37% | 6.70% | 6.05% | 6.62% | 4.36% | 7.99% | 4.56% | 5.23% | 4.93% | 5.30% |
Free Cash Flow Yield |
15.64% | 10.79% | 10.24% | 4.11% | 4.25% | 2.75% | 1.56% | 3.56% | 3.58% | 3.84% |
Revenue per Share |
40.88 | 41.77 | 43.69 | 46.99 | 36.17 | 40.55 | 43.84 | 48.25 | 53.79 | 59.06 |
Operating CF per Share |
7.19 | 7.03 | 7.79 | 6.48 | 7.15 | 7.23 | 7.11 | 8.55 | 10.04 | 11.70 |
Capex per Share |
(2.01) | (2.65) | (2.82) | (4.12) | (4.10) | (5.58) | (5.99) | (5.86) | (6.43) | (7.33) |
Free Cash Flow per Share |
5.18 | 4.37 | 4.97 | 2.36 | 3.04 | 1.65 | 1.13 | 2.69 | 3.61 | 4.37 |
Cash per Share |
1.14 | 1.25 | 1.31 | 1.55 | 2.94 | 1.13 | 0.54 | 1.05 | 1.23 | 1.02 |
Shareholders Equity per Share |
10.42 | 14.89 | 15.90 | 17.28 | 19.98 | 23.81 | 18.41 | 22.67 | 27.96 | 32.01 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
10.42 | 14.89 | 15.90 | 17.28 | 19.98 | 23.81 | 18.41 | 22.67 | 27.96 | 32.01 |
Free Cash Flow |
461.20 | 409.60 | 486.20 | 231.20 | 300.10 | 163.60 | 111.60 | 267.70 | 360.30 | 439.20 |
Working Capital |
178.90 | 184.70 | (10.40) | 34.80 | 231.30 | 172.60 | 141.30 | 185.40 | 45.90 | 69.50 |
Capital Expenditures |
(179.00) | (248.70) | (276.20) | (404.10) | (404.60) | (552.20) | (594.20) | (583.10) | (642.50) | (736.40) |
Net Current Asset Value |
(3,098.70) | (2,766.90) | (2,955.90) | (3,631.80) | (3,527.30) | (3,586.50) | (3,093.00) | (3,005.40) | (2,855.10) | (2,966.30) |
EV/EBIT |
9.04 | 9.85 | 11.42 | 12.14 | 18.06 | 12.62 | 13.67 | 12.70 | 13.43 | 12.40 |
Capex to Sales |
0.05 | 0.06 | 0.06 | 0.09 | 0.11 | 0.14 | 0.14 | 0.12 | 0.12 | 0.12 |
Price to Operating Income |
4.54 | 6.00 | 7.63 | 7.89 | 12.35 | 7.81 | 9.36 | 9.13 | 10.68 | 10.13 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.13 | 0.13 | 0.12 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.08 | 0.08 |
Cash ROIC |
11.40% | 10.01% | 11.58% | 4.71% | 5.41% | 2.85% | 2.40% | 5.28% | 6.66% | 7.56% |
Accounts Receivable Turnover |
8.53 | 8.55 | 9.10 | 9.46 | 6.61 | 7.38 | 8.26 | 8.36 | 8.88 | 9.75 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
427.15 | 457.95 | 469.90 | 486.90 | 539.45 | 544.30 | 526.30 | 574.20 | 605.20 | 609.00 |
Average Payables |
64.95 | 73.35 | 84.20 | 92.30 | 104.80 | 124.50 | 133.45 | 151.45 | 170.50 | 174.60 |
Average Assets |
4,644.00 | 4,773.20 | 5,019.75 | 5,627.85 | 6,263.30 | 6,655.40 | 6,250.70 | 5,869.45 | 6,318.55 | 6,812.20 |
Average Common Equity |
854.00 | 1,162.05 | 1,476.20 | 1,625.05 | 1,831.55 | 2,163.50 | 2,091.65 | 2,040.75 | 2,523.95 | 3,005.10 |
Columns are period end dates